Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
basic toxicokinetics
Type of information:
other: Weight of evidence
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)

Data source

Reference
Reference Type:
other: Weight of evidence
Title:
Toxicokinetics
Author:
Sustainability Support Services (Europe) AB
Year:
2012
Bibliographic source:
Based on the weight of evidence of various phys chem and bioaccumulative parameters in the dossier

Materials and methods

Objective of study:
toxicokinetics
Test guideline
Qualifier:
no guideline available
Principles of method if other than guideline:
Based on the weight of evidence of various phys chem and bioaccumulative parameters in the dossier
GLP compliance:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Benzidine-2,2'-disulphonic acid
EC Number:
204-200-0
EC Name:
Benzidine-2,2'-disulphonic acid
Cas Number:
117-61-3
Molecular formula:
C12H12N2O6S2
IUPAC Name:
4,4'-diamino-[1,1'-biphenyl]-2,2'-disulfonic acid
Test material form:
solid: crystalline
Details on test material:
- Name of test material: Benzidine-2,2’-disulphonic acid
- Molecular formula: C12H12N2O6S2
- Molecular weight: 344.369
Radiolabelling:
not specified

Test animals

Species:
other: unspecified
Strain:
not specified
Sex:
not specified

Administration / exposure

Route of administration:
other: estimation
Vehicle:
unchanged (no vehicle)
Control animals:
not specified

Results and discussion

Toxicokinetic / pharmacokinetic studies

Details on absorption:
The absorption capacity of benzidine-2,2'-disulphonic acid through inhalation route is low (given the extremely low vapour pressure). Absorption through the oral route is also likely to be low given the use of this chemical which is used for the preparation of other chemicals. Thus, dermal route is the most likely route of absorption. However, absorption through the dermal route is expected to be low given the particle size of the chemical which varies from 75 to 150 micrometer in size

Details on distribution in tissues:
In case, the chemical, benzidine-2,2'-disulphonic acid, is absorbed (though in small quantity) it shall not be easily distributed to various parts of the body through blood since the solubility of this chemical in water is moderate. It could be distributed in the lipids within the living system (given its higher solubility in organic solvents). However, since the bio-concentration factor (BCF) of the chemical is very low (ranging from 1.12 to 3.2), it will not be accumulated in the body
Details on excretion:
Further to this distribution after the absorption process, the excretion process through urine would be faster as the molecular weight of the substance, benzidine-2,2'-disulphonic acid, is > 300 and this is normally a favorable value for excretion via the urine route. Some amount of the absorbed chemical can also be excreted through the bile and feaces as the bio-accumulation potential of this chemical is low.

Metabolite characterisation studies

Metabolites identified:
no

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information): low bioaccumulation potential based on study results
The substance, benzidine-2,2'-disulphonic acid, is expected to have low bioaccumulation potential based on estimation results supported by the facts of physicochemical parameters and bio-accumulation potential of the substance.
Executive summary:

The substance, benzidine-2,2'-disulphonic acid, is expected to have low bioaccumulation potential based on estimation results supported by the facts of physicochemical parameters and bio-accumulation potential of the substance.